CBU
INDV icon

CIBC Bancorp USA’s Indivior Pharmaceuticals INDV Stock Holding History

CIBC Bancorp USA’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Buy
+6,687
New +$243K ﹤0.01% 1584
2025
Q3 		$312K Buy
+12,932
New +$271K ﹤0.01% 1061

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Bancorp USA's INDV Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 6,687 shares worth $274K. The stake represents ﹤0.01% of the portfolio and ranks #1584 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in INDV as recently as Q3 2025.

CIBC Bancorp USA first reported a position in INDV in Q3 2025 and has held it in 2 quarters since. The position peaked at $312K in Q3 2025. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • CIBC Bancorp USA held 6,687 shares of Indivior Pharmaceuticals worth $274K as of Q2 2026.
  • Indivior Pharmaceuticals was a new CIBC Bancorp USA position in Q2 2026.
  • Indivior Pharmaceuticals made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1584 holding.
  • CIBC Bancorp USA first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • CIBC Bancorp USA's Indivior Pharmaceuticals position peaked at $312K in Q3 2025.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.